Drug Industry
Colby Cosh links and comments on this article by Derek Lowe about how a lot of Americans are going up to Canada to buy the same drugs there because they are cheaper. He basically suggests that we shouldn’t follow the Canadian drug plan model because it doesn’t lead to ingenuity in the end.
Well, I think he does a good job of explaining this position and I agree with him in several respects, except for one major point: to my knowledge, the Canadian Government does not subsidize drugs. At least, that is what a pharmacist friend told me. I may have to double check on that, but I was always under the impression that lower liability insurance was the cause of the lower prices in Canada.
Colby also ends with a good point:
Perhaps we'll legislate the drugs to be cheap as they are in Canada, oh happy day. But before we do that, I'd like for people to know that I work with a number of talented Canadian researchers. We have folks from Newfoundland to Vancouver; all I have to do is go up and down the hall to cover the whole country. Doubtless several of them would prefer to have stayed and worked in the country they grew up in. It's not like Canada lacks the infrastructure--there are plenty of high tech companies up there, of course. But those companies are allowed to charge what they think the market will bear. What Canada doesn't have, for some reason, is a drug industry.
I couldn’t agree with this any more. Canada, for as advanced a nation as it is, has little drug industry. I’m speaking as someone who used to work in the Canadian healthcare field and who still has contacts (i.e. family members) in it. I’ll give one example. My father is good friends with a CEO of a Canadian start-up drug company based in Edmonton. For the sake of anonymity, I will not mention the name of the company. This firm had some really promising research, especially in the cancer field. The problem was the lack of funding. They just couldn’t get enough capital from within Canada to fund their research, so branched out to the US and Europe for money. While the company is still based in Edmonton, they do a lot of their R&D in the US (in Central New Jersey, to be more specific) now.
Point is that Canadian start-ups don’t have the right climate to thrive up there, so they must branch out or even relocate to other places to garner more success. Canada does lag behind other nations when it comes to drug-related research; the US, Europe (more specifically Germany, the UK and Switzerland) and even Japan have been doing some great things in the pharmaceutical industry. Quite a tragedy, really, considering it’s a waste of so much potential.
Update: Just heard from a very reliable source that the company is in a lot of trouble and has been losing a lot of money since its conception. Also, they never really had a large US presence to begin with, just an office to attract investment.
Now, in no way shape or form am I suggesting that the fact that the majority of this company’s operations are in Canada is the cause of its financial malaise. But I do find it somewhat interesting that a pharmaceutical company can be losing so much money as they are traditionally stable and profitable. This is, indeed, perplexing.
